Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 "DEFUSE 3"


Phase N/A Results N/A

Summary of Purpose

This is a study to evaluate the hypothesis that FDA cleared thrombectomy devices plus medical management leads to superior clinical outcomes in acute ischemic stroke patients at 90 days when compared to medical management alone in appropriately selected subjects with the Target mismatch profile and an MCA (M1 segment) or... Trial Stopped: Interim analysis showed a high likelihood of benefit in the endovascular group

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 November 2017.

1 Apr 2016 21 Oct 2015 23 Aug 2017 23 Aug 2017 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment